Remove tag change-control
article thumbnail

Grand Rounds December 2, 2022: A Randomized Controlled Trial of Mobile Health Intervention in Heart Failure and Diabetes: Lessons Learned (G. Michael Felker, MD, MHS)

Rethinking Clinical Trials

Making lifestyle changes is difficult especially for people living with chronic diseases, where healthy behaviors could make a big difference. The TARGET-HF-DM is a pragmatic multicenter randomized controlled trial held at 6 sites in the U.S. The primary endpoint was change in mean daily step counts from baseline to 3 months.

Trials 130
article thumbnail

Grand Rounds September 22, 2023: Integrating Community Health Workers into Team-Based, Early Childhood Preventative Care (Tumaini Rucker Coker, MD, MBA)

Rethinking Clinical Trials

The Parent-Focused Redesign for Encounters, Newborns to Toddlers (PARENT) study was a randomized controlled trial of PARENT verses usual care for parents with infants 12 months and younger over a 12-month study period. Discussion Themes -What did stakeholder engagement change in the process? The average child age was 4 months.

Trials 278
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Are You Ready for GA4? Enhancements for Measuring Engagement

Intouch Solutions

In October 2020 , Google introduced Google Analytics 4 (GA4) as its next data model to keep up with these changes while safeguarding privacy. Now is the time to prepare, learn about the changes and pivot the way you’re tracking brand ROI. However, marketers could still utilize standard Universal Analytics to process data.

article thumbnail

Grand Rounds March 17, 2023: Remote Symptom Monitoring with Electronic Patient-Reported Outcomes (ePROs) in Oncology (Ethan Basch, MD, MSc)

Rethinking Clinical Trials

Symptom control enables patients to stay more functional, which is known to be associated with better survival. Symptom monitoring enables control of chemotherapy side effects, enabling more intensive and longer duration of cancer treatment. The culture has fundamentally changed. community oncology practices across 25 states.

article thumbnail

Grand Rounds Ethics and Regulatory Series November 11, 2022: Data Sharing and Pragmatic Clinical Trials: Law & Ethics Amidst a Changing Policy Landscape (Stephanie Morain, PhD, MPH; Kayte Spector-Bagdady, JD, MBioethics)

Rethinking Clinical Trials

clinicians, health systems), data may have been collective for administrative/clinical purposes, data may be more representative of “real world” conditions, and data may be controlled by a third party (e.g. For PCTs, data volume is potentially larger, data may be “about” those beyond patient-subjects (i.e. pctGR, @Collaboratory1.

article thumbnail

Grand Rounds September 15, 2023: Effect of Financial Incentives and Default Options on Food Choices of Adults With Low Income in Online Retail Settings (Pasquale Rummo, PhD, MPH)

Rethinking Clinical Trials

About half of those in the control and discount groups purchased at least one of the fruits and vegetables offered to the default group on their own accord. I want to acknowledge that there’s definitely questions about the sustainability of types of behavior changes like the default options or even the economic incentives.

article thumbnail

Grand Rounds August 4, 2023: AI & ML: Want to Play a Game? (Eric Perakslis, PhD)

Rethinking Clinical Trials

The key is to have a deep understanding and control over the data being used. The smallest change in data can completely change the results when AI is involved. The important thing is to learn and adapt to the changes. Tags #pctGR, @Collaboratory1 The post Grand Rounds August 4, 2023: AI & ML: Want to Play a Game?